155 related articles for article (PubMed ID: 2447406)
1. Comparative effects of procainamide and its N-acetylated metabolite in conscious dogs with atrioventricular block: plasma concentration-response relationships.
Boucher M; Dubray C; Paire M; Duchêne-Marullaz P
J Cardiovasc Pharmacol; 1987 Nov; 10(5):562-7. PubMed ID: 2447406
[TBL] [Abstract][Full Text] [Related]
2. Comparison of the autonomic effects of procainamide and N-acetylprocainamide in the dog.
Reynolds RD; Gorczynski RJ
J Pharmacol Exp Ther; 1980 Mar; 212(3):579-83. PubMed ID: 6153717
[TBL] [Abstract][Full Text] [Related]
3. Hemodynamic effects of n-acetylprocainamide compared with procainamide in conscious dogs.
Badke FR; Walsh RA; Crawford MH; Ludden T; O'Rourke RA
Circulation; 1981 Dec; 64(6):1142-50. PubMed ID: 6170473
[TBL] [Abstract][Full Text] [Related]
4. Comparative vagolytic effects of procainamide and N-acetylprocainamide in the dog.
Pearle DL; Souza JD; Gillis RA
J Cardiovasc Pharmacol; 1983; 5(3):450-3. PubMed ID: 6191146
[TBL] [Abstract][Full Text] [Related]
5. Cardiac anticholinergic effects of procainamide and its N-acetylated metabolite: experimental pharmacological and radioligand binding studies.
Boucher M; Chassaing C; Laborde P; Breysse C; Herbet A
J Auton Pharmacol; 1998 Apr; 18(2):83-7. PubMed ID: 9730262
[TBL] [Abstract][Full Text] [Related]
6. The inotropic actions of N-acetylprocainamide: blockade and reversal by propranolol.
Lertora JJ; King LW; Donkor KA
Angiology; 1986 Dec; 37(12 Pt 2):939-49. PubMed ID: 2433968
[TBL] [Abstract][Full Text] [Related]
7. Electrophysiologic effects of N-acetylprocainamide in human beings.
Jaillon P; Rubenson D; Peters F; Mason JW; Winkle RA
Am J Cardiol; 1981 May; 47(5):1134-40. PubMed ID: 6164285
[TBL] [Abstract][Full Text] [Related]
8. Comparative effects of disopyramide and its mono-N-dealkylated metabolite in conscious dogs with chronic atrioventricular block: plasma concentration-response relationships.
Dubray C; Boucher M; Paire M; Pinatel H; Duchêne-Marullaz P
J Cardiovasc Pharmacol; 1986; 8(6):1229-34. PubMed ID: 2434751
[TBL] [Abstract][Full Text] [Related]
9. Serum levels and electrophysiological effects of N-acetlyprocainamide as compared with procainamide in the dog heart in situ.
Amlie JP; Nesje OA; Frislid K; Lunde PK; Landmark K
Acta Pharmacol Toxicol (Copenh); 1978 Apr; 42(4):280-6. PubMed ID: 580675
[TBL] [Abstract][Full Text] [Related]
10. In vivo and in vitro antiarrhythmic and arrhythmogenic effects of N-acetyl procainamide.
Dangman KH; Hoffman BF
J Pharmacol Exp Ther; 1981 Jun; 217(3):851-62. PubMed ID: 6164783
[TBL] [Abstract][Full Text] [Related]
11. Comparison of the pharmacokinetic and pharmacodynamic properties of procainamide and N-acetylprocainamide.
Atkinson AJ; Ruo TI; Piergies AA
Angiology; 1988 Jul; 39(7 Pt 2):655-67. PubMed ID: 2457345
[TBL] [Abstract][Full Text] [Related]
12. Kinetic analysis of the vasodilator and ganglionic blocking actions of N-acetylprocainamide.
Eudeikis JR; Henthorn TK; Lertora JJ; Atkinson AJ; Chao GC; Kushner W
J Cardiovasc Pharmacol; 1982; 4(2):303-9. PubMed ID: 6175815
[TBL] [Abstract][Full Text] [Related]
13. Electrophysiologic properties and antiarrhythmic mechanisms of intravenous N-acetylprocainamide in patients with ventricular dysrhythmias.
Sung RJ; Juma Z; Saksena S
Am Heart J; 1983 May; 105(5):811-9. PubMed ID: 6189384
[TBL] [Abstract][Full Text] [Related]
14. Effects of N-acetylprocainamide on experimental atrial flutter and atrial electrophysiologic properties in conscious dogs with sterile pericarditis: comparison with the effects of quinidine.
Okumura K; Waldo AL
J Am Coll Cardiol; 1987 Jun; 9(6):1332-8. PubMed ID: 2438320
[TBL] [Abstract][Full Text] [Related]
15. Electrophysiologic evaluation of the antiarrhythmic effects of N-acetylprocainamide for ventricular tachycardia secondary to coronary artery disease.
Wynn J; Miura DS; Torres V; Flowers D; Keefe D; Williams S; Somberg JC
Am J Cardiol; 1985 Nov; 56(13):877-81. PubMed ID: 2414983
[TBL] [Abstract][Full Text] [Related]
16. [A new anti-arrhythmia drug. II. Comparative studies of the effects of a new acyl derivative of procainamide, procainamide and N-acetylprocainamide on blood pressure and the electrocardiogram in rabbits].
Kusowska J
Acta Pol Pharm; 1989; 46(1):90-7. PubMed ID: 2479226
[TBL] [Abstract][Full Text] [Related]
17. Electropharmacodynamics of N-acetylprocainamide in the immature mammalian heart--evidence for a prominent class III effect in the newborn.
Dise T; Stolfi A; Yamasaki S; Pickoff AS
J Cardiovasc Pharmacol; 1991 Jan; 17(1):96-101. PubMed ID: 1708063
[TBL] [Abstract][Full Text] [Related]
18. Electrophysiologic interactions of procainamide and N-acetylprocainamide in isolated canine cardiac Purkinje fibers.
Coyle JD; Carnes CA; Schaal SF; Muir WW
J Cardiovasc Pharmacol; 1992 Aug; 20(2):197-205. PubMed ID: 1381010
[TBL] [Abstract][Full Text] [Related]
19. Hemodynamic effects of N-acetylprocainamide in heart disease.
Crawford MH; Ludden TM; Kennedy GT; Sodums MT; O'Rourke RA; Amon KW
Clin Pharmacol Ther; 1982 Apr; 31(4):459-65. PubMed ID: 6174263
[TBL] [Abstract][Full Text] [Related]
20. Electrophysiologic comparative study of procainamide and N-acetylprocainamide in anesthetized dogs: concentration-response relationships.
Jaillon P; Winkle RA
Circulation; 1979 Dec; 60(6):1385-94. PubMed ID: 91451
[No Abstract] [Full Text] [Related]
[Next] [New Search]
